Fei Yu
- Infectious Diseases top 2%
- Epidemiology top 5%
- Molecular Biology
- Hepatology top 2%
- Obstetrics and Gynecology top 2%
- Co-authors
- Shibo JiangFiona McPheeQianqian ZhangRong XiangShanshan HuoQiao WangYunjiao ZhouShufa Zheng
- Topics
- Hepatitis C virus research (17 papers)HIV/AIDS drug development and treatment (13 papers)SARS-CoV-2 and COVID-19 Research (10 papers)
- Journals
- Angewandte Chemie International EditionThe Journal of Experimental MedicineGastroenterology
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Fei Yu
80 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 126
- Infectious Diseases 697
- Epidemiology 538
- Molecular Biology 489
- Hepatology 486
- Obstetrics and Gynecology 262
Countries citing papers authored by Fei Yu
This map shows the geographic impact of Fei Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Yu more than expected).
Fields of papers citing papers by Fei Yu
This network shows the impact of papers produced by Fei Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Yu. The network helps show where Fei Yu may publish in the future.
Co-authorship network of co-authors of Fei Yu
This figure shows the co-authorship network connecting the top 25 collaborators of Fei Yu. A scholar is included among the top collaborators of Fei Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fei Yu. Fei Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 5 | |
| 5 | 1 | |
| 6 | 4 | |
| 7 | 14 | |
| 8 | 6 | |
| 9 | 22 | |
| 10 | 48 | |
| 11 | 19 | |
| 12 | 10 | |
| 13 | Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapybreakdown → | 234 |
| 14 | 5 | |
| 15 | 16 | |
| 16 | 5 | |
| 17 | 27 | |
| 18 | 22 | |
| 19 | 111 | |
| 20 | 98 |
About Fei Yu
Fei Yu is a scholar working on Virology, Hepatology and Infectious Diseases, having authored 88 papers that have together received 2.0k indexed citations. Recurring topics across this work include Hepatitis C virus research (17 papers), HIV/AIDS drug development and treatment (13 papers) and SARS-CoV-2 and COVID-19 Research (10 papers). The work is most often cited by research in Hepatology (486 citations), Infectious Diseases (697 citations) and Obstetrics and Gynecology (262 citations). Fei Yu has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Shibo Jiang, Fiona McPhee, Qianqian Zhang, Rong Xiang, Shanshan Huo, Qiao Wang, Yunjiao Zhou, Shufa Zheng, Dennis Hernandez and Jifang Sheng. Their work appears in journals such as Angewandte Chemie International Edition, The Journal of Experimental Medicine and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.